Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001871002-23-000004

SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $51.06 ($1,021,200)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gassert Chad SVP - CORP. DEV. & STRATEGY 2023-08-01 Sale 10b5-1 −20,000 $51.06 $1,021,200 333,226 I
Open-market sales · 20,000 sh · avg $51.06 · $1,021,200
Loading xslF345X05/wk-form4_1691100197.xml…